SABS
SAB Biotherapeutics, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 3:57:18 PM EST
2.90USD-9.375%(-0.30)1,672,993
SABS News
SAB Biotherapeutics at UBS conference: late-stage diabetes bet ·
Investing.com
SAB Biotherapeutics (SABS) Q3 2026 Earnings Call Transcript ·
The Motley Fool
SAB Biotherapeutics reports Q3 results ·
Seeking Alpha
SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights ·
GlobeNewswire Inc.
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference ·
GlobeNewswire Inc.
SAB BIO Receives FDA Fast Track Designation for SAB-142 in Stage 3 Type 1 Diabetes ·
GlobeNewswire Inc.